cognitive cybersecurity intelligence

News and Analysis

Search

Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

Agreement offers exclusive rights to commercialize six products in key areas of anti-infectives and oncology.Products from Adalvo slated for near- to mid-term launches, with four out of six anticipated to be first-to-marketSandoz continues to expand patient access to much-needed medications,…

Source: www.novartis.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

A National Imperative – Cyber Resiliency

Cybersecurity expert Andrea E. Davis emphasizes the increasing vulnerability of critical infrastructure to cyber threats, highlighting instances such as the 2003 US and Canada power